Related Experiment Videos
Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas
The Indian Journal of Medical Research
|March 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Pattern of Malignant Lymphoma in India: A Study of 1371 Cases.
Leukemia & lymphoma·2016
Clinical evaluation of sahacharadi and nirgundi tailas in saisaveeyavata (poliomyelitis).
Ancient science of life·2012
Cancer survival in Barshi, India, 1993-2000.
IARC scientific publications·2011
Visfatin--a review.
European review for medical and pharmacological sciences·2011
Whole-body PET acceptance test in 2D and 3D using NEMA NU 2-2001 protocol.
Journal of medical physics·2011
Comparison of heart rate variability in normotensive and newly detected hypertensive adults in a tertiary care hospital, Mysuru, Karnataka.
The Indian journal of medical research·2026
Seroprevalence of varicella antibodies in unvaccinated children with nephrotic syndrome in disease remission.
The Indian journal of medical research·2026
Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals.
The Indian journal of medical research·2026
Prevalence, risk-factors and early prediction of impaired kidney function among indigenous adults in Odisha, India: A secondary analysis.
The Indian journal of medical research·2026
Association of dietary diversity with anaemia among children (6 mo-9 y) in Puducherry, South India: A cross-sectional study.
The Indian journal of medical research·2026
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026